Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

Many women with PCOS have abnormal cholesterol levels, needing careful management.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

The document concludes that managing PCOS effectively requires considering ethnic differences, obesity's impact, and ethical concerns in treatment approaches.

High androgen levels often cause female hirsutism and infertility.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

Accurate diagnosis of PCOS requires comprehensive androgen measurement.

High insulin levels are more common and a better predictor of carbohydrate issues in women with PCOS than glucose tolerance tests.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Oligomenorrhea is the strongest predictor of PCOS severity.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.

Hirsutism, excessive hair growth in women, is often caused by polycystic ovarian syndrome and is treated by targeting the cause, lifestyle changes, and medication.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Including androgens in hormone therapy may lower breast cancer risk.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hirsutism severity is linked to androgen levels, especially in women with a lower LH/FSH ratio.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.